Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Lung cancer patients can expect improved long term survival under a new treatment combination, according to new Irish ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

Prof Patrick Forde of the Trinity St James’s Cancer Institute presented the findings at the latest meeting of the American ...

Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, ...

However, the report also indicates that cancer diagnoses have increased by almost half (47 per cent) across Great Britain ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

CHICAGO -- Neoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with ...

CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...